Portosystemic collaterals are not prerequisites for the development of hepatic encephalopathy in cirrhotic rats

Journal of the Chinese Medical Association

Volumn 75, Issue 1, 2012, Pages 3-9

  Hsin, I Fang ^a   Wang, Sun Sang ^a,b   Huang, Hui Chun ^a,b   Lee, Fa Yauh ^a,b   Chan, Cho Yu ^b,c   Chang, Ching Chih ^a,b   Hsu, Chia Yang ^b   Lin, Han Chieh ^a,b   Lee, Shou Dong ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Hepatic encephalopathy; Liver cirrhosis; Portal hypertension; Portal systemic collaterals; Tumor necrosis factor

Indexed keywords

ASPARTATE AMINOTRANSFERASE; BILIRUBIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE DUCT LIGATION; BILIRUBIN BLOOD LEVEL; CHEMISTRY; CONTROLLED STUDY; DISEASE SEVERITY; FLOW RATE; HEPATIC ENCEPHALOPATHY; LIVER CIRRHOSIS; LIVER INJURY; MALE; MOTOR ACTIVITY; NONHUMAN; PORTAL HYPERTENSION; PORTAL VEIN; PORTOSYSTEMIC ANASTOMOSIS; PROTEIN EXPRESSION; RAT; SHAM PROCEDURE;

ANIMALS; COLLATERAL CIRCULATION; DISEASE MODELS, ANIMAL; HEMODYNAMICS; HEPATIC ENCEPHALOPATHY; HYPERTENSION, PORTAL; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; MOTOR ACTIVITY; PORTAL SYSTEM; RATS; RATS, SPRAGUE-DAWLEY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84855612256     PISSN: 17264901     EISSN: 17287731     Source Type: Journal    
DOI: 10.1016/j.jcma.2011.10.008     Document Type: Article

References (32)

1. Gammal S.H., Jones E.A. Hepatic encephalopathy. Med Clin North Am 1989, 73:793-813.
2. Mousseau D.D., Butterworth R.F. Current theories on the pathogenesis of hepatic encephalopathy. Soc Exp Biol Med 1994, 206:329-344.
3. Geraghty J.G., Angerson W.J., Carter D.C. Portal venous pressure and portasystemic shunting in experimental portal hypertension. Am J Physiol 1989, 257:G52-G57.
4. Vogels B.A., van Steynen B., Maas M.A., Jorning G.G., Chamuleau R.A. The effect of ammonia and portal-systemic shunting on brain metabolism, neurotransmission and intracranial hypertension in hyperammonaemia-induced encephalopathy. J Hepatol 1997, 26:387-395.
5. Borrelli E., Roux-Lombard P., Grau G.E., Ricou B., Dayer J., Suter P.M. Plasma concentrations of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at risk. Crit Care Med 1996, 24:392-397.
6. Sztrymf B., Rabiller A., Nunes H., Savale L., Lebrec D., Le Pape A., et al. Prevention of hepatopulmonary syndrome and hyperdynamic state by pentoxifylline in cirrhotic rats. Eur Respir J 2004, 23:752-758.
7. Chu C.J., Lee F.Y., Wang S.S., Lu R.H., Tsai Y.T., Lin H.C., et al. Hyperdynamic circulation of cirrhotic rats with ascites: role of endotoxin, tumour necrosis factor-alpha and nitric oxide. Clin Sci (Lond) 1997, 93:219-225.
8. Kerfoot S.M., D'Mello C., Nguyen H., Ajuebor M.N., Kubes P., Le T., et al. TNF-α- secreting monocytes are recruited into the brain of cholestatic mice. Hepatology 2006, 43:154-162.
9. Chu C.J., Chen C.T., Wang S.S., Lee F.Y., Chang F.Y., Lin H.C., et al. Hepatic encephalopathy in rats with thioacetamide-induced fulminant hepatic failure: role of endotoxin and tumor necrosis factor-alpha. J Chin Med Assoc 2001, 64:321-330.
10. Kountouras J., Billing B.H., Scheuer P.J. Prolonged bile duct obstruction: a new experimental model for cirrhosis in rat. Br J Exp Pathol 1984, 65:305-311.
11. Lebrec D., Blanchet L. Effect of two models of portal hypertension on splanchnic organ blood flow in the rat. Clin Sci 1985, 68:23-28.
12. Chojkier M., Groszmann R.J. Measurement of portal-systemic shunting in the rat by using γ-labeled microspheres. Am J Physiol 1981, 240:G371-G375.
13. Fernandez M., Pizcueta P., Garcia-Pagan J.C., Feu F., Cirera I., Bosch J., et al. Effects of ritanserin, a selective and specific S2-serotoninergic antagonist, on portal pressure and splanchnic hemodynamics in rats with long-term bile duct ligation. Hepatology 1993, 18:389-393.
14. Bengtsson F., Gage F.H., Jeppsson B., Nobin A., Rosengren E. Brain monoamine metabolism and behavior in portacaval shunted rats. Exp Neurol 1985, 90:21-35.
15. Wang S.S., Chan C.C., Lee F.Y., Chang F.Y., Lin H.C., Chen C.T., et al. Effects of long-term octreotide treatment on the response of portal-systemic collaterals to vasopressin in portal hypertensive rats. Eur J Clin Invest 2002, 32:316-321.
16. Lee F.Y., Wang S.S., Tsai Y.T., Lin H.J., Lin H.C., Chu C.J., et al. Aminoguanidine corrects hyperdynamic circulation without ameliorating portal hypertension and portal hypertensive gastropathy in anesthetized portal hypertensive rats. J Hepatol 1997, 26:687-693.
17. Mosca P., Lee F.Y., Kaumann A.J., Groszmann R.J. Pharmacology of portal-systemic collaterals in portal hypertensive rats: role of endothelium. Am J Physiol. 1992, 263:G544-G550.
18. Lee F.Y., Colombato L.A., Albillos A., Groszmann R.J. Administration of N-omega-nitro-L-arginine ameliorates portal-systemic shunting in portal- hypertensive rats. Gastroenterology 1993, 105:1464-1470.
19. Chan C.C., Lee F.Y., Wang S.S., Chang F.Y., Lin H.C., Chu C.J., et al. Effects of vasopressin on portal-systemic collaterals in portal hypertensive rats: role of nitric oxide and prostaglandin. Hepatology 1999, 30:630-635.
20. Hamilton R.L., Berry M.N., Williams M.C., Severinghaus E.M. A simple and inexpensive membrane "lung" for small organ perfusions. J Lipid Res 1974, 15:182-186.
21. Vaquero J., Chung C., Cahill M.E., Blei A.T. Pathogenesis of hepatic encephalopathy in acute liver failure. Semin Liver Dis 2003, 23:259-269.
22. Haussinger D., Kircheis G., Fischer R., Schliess F., vom Dahl S. Hepatic encephalopathy in chronic liver disease: a clinical manifestation of astrocytes swelling and low-grade cerebral edema. J Hepatol 2000, 32:1035-1038.
23. Chu C.J., Wang S.S., Lee F.Y., Chang F.Y., Lin H.C., Hou M.C., et al. Detrimental effects of nitric oxide inhibition on hepatic encephalopathy in rats with thioacetamide-induced fulminant hepatic failure. Eur J Clin Invest 2001, 31:156-163.
24. Rahman T.M., Hodgson H.J. Animal models of acute hepatic failure. Int J Exp Pathol 2000, 81:145-157.
25. Rigotti P., Jonung T., James J.H., Edwards L.L., Peters J.C., Fischer J.E. Infusion of branched-chain amino acids and ammonium salts in rats with portacaval shunts. Arch Surg 1985, 120:1290-1295.
26. Hawkins P.A., DeJoseph M.R., Vina J.R., Hawkins R.A. Comparison of the metabolic disturbances caused by end-to-side and side-to-side portacaval shunts. J Appl Physiol 1996, 80:885-891.
27. Chu C.J., Lee F.Y., Wang S.S., Chang F.Y., Lin H.C., Wu S.L., et al. Establishment of an animal model of hepatic encephalopathy. J Chin Med Assoc 2000, 63:263-269.
28. Chan C.Y., Huang S.W., Wang T.F., Lu R.H., Lee F.Y., Chang F.Y., et al. Lack of detrimental effects of nitric oxide inhibition in bile duct-ligated rats with hepatic encephalopathy. Eur J Clin Invest 2004, 34:122-128.
29. Sikuler E., Kravetz E.D., Groszmann R.J. Evolution of portal hypertension and mechanisms involved in its maintenance in a rat model. Am J Physiol 1985, 248:G618-G625.
30. Jiang W., Desjardins P., Butterworth R.F. Direct evidence for central proinflammatory mechanisms in rats with experimental acute liver failure: protective effect of hypothermia. J. Cereb Blood Flow Metab 2009, 29:944-952.
31. Montagnese S., Biancardi A., Schiff S., Carraro P., Carla V., Mannaioni G., et al. Different biochemical correlates for different neuropsychiatric abnormalities in patients with cirrhosis. Hepatology 2011, 53:558-566.
32. Bémeur C., Qu H., Desjardins P., Butterworth R.F. IL-1 or TNF receptor gene deletion delays onset of encephalopathy and attenuates brain edema in experimental acute liver failure. Neurochem Int 2010, 56:213-215.